Digoxin-specific antibody fragments in the treatment of digoxin toxicity
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/08/04
-
Journal
-
Indian UGC (journal)
-
Refrences69
-
Citations79
-
B. S. H. Chan
-
N. A. Buckley
Cite
Chan, B. S. H., and N. A. Buckley. “Digoxin-Specific Antibody Fragments in the Treatment of Digoxin Toxicity”. Clinical Toxicology, vol. 52, no. 8, 2014, pp. 824-36, https://doi.org/10.3109/15563650.2014.943907.
Chan, B. S. H., & Buckley, N. A. (2014). Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clinical Toxicology, 52(8), 824-836. https://doi.org/10.3109/15563650.2014.943907
Chan, B. S. H., and N. A. Buckley. “Digoxin-Specific Antibody Fragments in the Treatment of Digoxin Toxicity”. Clinical Toxicology 52, no. 8 (2014): 824-36. https://doi.org/10.3109/15563650.2014.943907.
Chan BSH, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clinical Toxicology. 2014;52(8):824-36.
Journal Category
Medicine
Public aspects of medicine
Toxicology
Poisons
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Monitoring Serum Digoxin Concentrations during Digoxin Immune Fab Therapy | DICP | 1 | 1991 | |
Clinical and Pharmacokinetic Profiles of Digoxin Immune Fab in Four Patients with Renal Impairment | DICP | 5 | 1991 | |
Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose. | Clinical Chemistry |
| 44 | 1987 |
Fab Fragments of Digoxin-Specific Antibodies Used to Reverse Ventricular Fibrillation Induced by Digoxin Ingestion in a Child | Pediatrics |
| 34 | 1982 |
Digoxin pharmacokinetics: Role of renal failure in dosage regimen design | Clinical Pharmacology & Therapeutics |
| 70 | 1975 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Part I: Case series: Acute management of prescription and nonprescription drug overdoses | JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY |
| 2024 | |
| Biosensing-based quality control monitoring of the higher-order structures of therapeutic antibody domains | Analytica Chimica Acta |
| 2024 | |
| Poisoning with cardioactive substances | Medicine | 2024 | ||
Entrapment of Digoxin-KLH Conjugate in Alginate/Chitosan Nanoparticles:
A New Antigen Delivery System For Production of Anti-digoxin
Antibodies | Pharmaceutical Nanotechnology |
| 2024 | |
Unusual Tachycardia After Cocaine Use | JAMA Internal Medicine |
| 2 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 39
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Discrepancies in reported US pricing information for digoxin-Fab and was published in 2014. The most recent citation comes from a 2024 study titled Poisoning with cardioactive substances. This article reached its peak citation in 2019, with 13 citations. It has been cited in 49 different journals, 18% of which are open access. Among related journals, the Clinical Toxicology cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.